Archive for April, 2012

Yasmin Blood Clot Injury Lawsuit Settlements Climb to $142 Million

Filed April 26th, 2012 tmccoy

by: Jonathan Macri, Esq. Bayer AG, one of the world’s largest and most successful manufacturers of pharmaceuticals, has finally begun to get an idea of just how much their failure to warn users of the dangers of one of their most popular drugs is going to cost them. The company recently announced that settlements in [...]

9/11 First Responders Compensated Under the Zadroga Act

Filed April 26th, 2012 tmccoy

by: Matthew McCauley, Esq. Emergency personnel who first responded to the American tragedy of the World Trade Center were put at a high risk due to exposure to toxic dust and chemicals. These victims, which include loved ones who lost someone, are being compensated by the victims’ compensation fund. Health conditions being compensated for include [...]

Australians Join Class Action Lawsuit Against Johnson and Johnson for Failing Metal-on-Metal Hip Implants

Filed April 25th, 2012 tmccoy

by: Stephanie Herschaft, Esq. Over 1000 Australians have joined a multimillion-dollar class action against Johnson and Johnson after receiving controversial metal-on-metal hip implants manufactured by DePuy Orthopaedics, a subsidiary of Johnson and Johnson. An article in The Courier Mail chronicles the story of Stuart Cain, a plaintiff in the class action. In June 2007, Cain [...]

Boston Scientific Defibrillator Malfunction Kills Patient

Filed April 25th, 2012 tmccoy

by: Jonathan Macri, Esq. Boston Scientific has just issued a warning in relation to two of its implantable defibrillators, bringing the company under fire for the second time this year. The defibrillators at issue, Cognis and Telogen, are associated with 26 confirmed reports of malfunctions, and the warning comes after one of these incidents resulted [...]

Prescription Drug Avodart Linked to Prostate Cancer

Filed April 25th, 2012 tmccoy

by: Gary Falkowitz, Esq. Avodart is used to help reduce the chance of developing acute urinary retention (sudden inability to urinate) and also to treat the enlargement of the prostate gland. Avodart is a dutasteride medication manufactured by GlaxoSmithKline and approved by the Food and Drug Administration (FDA) in October 2002. Avodart is in a [...]

Bone Fractures Caused by Long-Term Exposure to Fosamax

Filed April 25th, 2012 tmccoy

by: Matthew McCauley, Esq. Osteopenia is a medical condition in which the density in a woman’s bone increases the risks of breaks. Treatment of this condition includes bisphosphonate prescription drugs such as Fosamax, Actonel, and Boniva. Recent studies have shown that long-term exposure to these drugs is causing atypical fractures in women. What this means [...]

Femur Fractures Caused by Osteoporosis Medicine

Filed April 24th, 2012 tmccoy

by: Matthew McCauley, Esq. Attorney Matthew McCauley shares a case study about a client named “Jane” who suffered a very painful femur fracture due to overexposure of a prescription drug. Jane was prescribed the prescription drug Fosamax for osteopenia, which is usually a precursor for osteoporosis. These medical conditions are a loss of bone density, [...]

The BP Oil Spill: The Plot Thickens

Filed April 24th, 2012 tmccoy

by: Jay Breakstone, Esq. One would think that with the recent BP Oil Spill settlement, all is right with the world and we can happily move on to the next environmental disaster. But after all is said and done, the question remains: What happened and who is to blame? Answering questions of liability become much [...]

Bladder Cancer Risk Increases With Actos Usage

Filed April 24th, 2012 tmccoy

by: Stephanie Herschaft, Esq. Actos (pioglitazone hydrochloride), an oral anti-diabetic drug, is authorized in Canada (and in the United States) to help decrease the blood glucose levels not controlled by diet and exercise alone, in patients who suffer from type 2 diabetes mellitus. ACTOS (pioglitazone hydrochloride) can also be taken with sulfonylurea or metformin when [...]

FDA Strengthens Monitoring of Post-Approval Drug Safety

Filed April 24th, 2012 tmccoy

by: Jonathan Macri, Esq. At last, the Food and Drug Administration is giving the same priority to drugs that have been released on the market to ones that are still in the pre-market review phase, and amidst an environment where new drug defects are seemingly found every day, the FDA’s new priorities seem to be [...]

    Free Case Review Form

    *    Denotes required field.

    * First Name

    Title1

    * Last Name

    * Email

    * Phone

    Cell Phone

    Office Phone

    Street Address

    Apartment/Suite

    Zip Code

    City

    State

    Please provide the best method and time to contact you:

    Date of birth (mm-dd-yyyy):

    Please describe your case:

    Date of Incident (mm-dd-yyyy):

    Other Info:

    No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review all.

    Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

    please do not fill out the field below.

To Get Help Now
Personal Injury Lawsuits
Click Here
  php-5 php-5